BPC-157 and TB-500 are two of the most studied research peptides in tissue and recovery research — and they're frequently mentioned together. This article breaks down what each one is, how they differ, and why researchers often study them side by side.

Quick Answer

Both are synthetic research peptides studied in tissue-related research, but they come from different origins and are studied for different mechanisms. BPC-157 derives from a gastric protein sequence; TB-500 is a synthetic fragment related to Thymosin Beta-4. Researchers often study them as a blend (labeled "BPC/TB") to compare or combine their effects in model systems.

What BPC-157 Is

BPC-157 ("Body Protection Compound") is a synthetic peptide based on a partial sequence found in gastric juice. In research literature it appears most often in studies of gastrointestinal and connective-tissue processes. It is supplied as a lyophilized vial, a nasal spray, or as part of a blend.

What TB-500 Is

TB-500 is a synthetic peptide fragment related to Thymosin Beta-4, a naturally occurring protein involved in cell movement and structural processes. In research it is studied for its role in cell migration and tissue-related pathways. It is typically supplied as a lyophilized vial.

Side-by-Side Comparison

Attribute	BPC-157	TB-500
Origin	Gastric protein sequence	Thymosin Beta-4 fragment
Commonly studied for	GI and connective-tissue processes	Cell migration and structural pathways
Typical research formats	Vial, nasal spray, blend	Vial, blend
Often combined?	Yes — frequently studied together as a "BPC/TB" blend

Why Researchers Study Them Together

Because the two peptides are studied for complementary tissue-related pathways, researchers often examine them in parallel — or as a pre-mixed blend — to compare individual versus combined effects in controlled model systems. This is why you'll frequently see a "BPC-157/TB-500" product offered alongside the individual compounds.

What Matters When Sourcing Either

Regardless of which you study, the same quality rules apply. Research-grade BPC-157 and TB-500 should be:

• Made in a controlled facility (Helio's are made in the USA)
• Batch produced and batch tested
• Purity-verified by HPLC (99%+) and identity-confirmed by mass spectrometry
• Shipped with a batch-specific Certificate of Analysis (COA)

Key Takeaways

• BPC-157 and TB-500 are different peptides with different origins, studied for related but distinct tissue pathways.
• They are frequently researched together, including as a pre-mixed blend.
• For research, insist on 99%+ purity, HPLC + mass-spec testing, and a batch COA.
• Both are intended for laboratory research use only.

Helio Peptides supplies BPC-157, TB-500, and BPC-157/TB-500 blends — made in the USA, third-party tested to 99%+ purity, and shipped with a Certificate of Analysis. View our BPC-157 and TB-500 research peptides →

Disclaimer: All products are intended solely for laboratory research and are not for human or animal consumption. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.